Cargando…
PDCD10 promotes the aggressive behaviors of pituitary adenomas by up-regulating CXCR2 and activating downstream AKT/ERK signaling
As the second most common primary intracranial neoplasms, about 40% of pituitary adenomas (PAs) exhibit aggressive behaviors and resulting in poor patient prognosis. The molecular mechanisms underlying the aggressive behaviors of PAs are not yet fully understood. Biochemical studies have reported th...
Autores principales: | Liu, Jingdian, Wang, Junwen, Tian, Weidong, Xu, Yu, Li, Ran, Zhao, Kai, You, Chao, Zhu, Yuan, Bartsch, Joerg Walter, Niu, Hongquan, Zhang, Huaqiu, Shu, Kai, Lei, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417224/ https://www.ncbi.nlm.nih.gov/pubmed/35963638 http://dx.doi.org/10.18632/aging.204206 |
Ejemplares similares
-
The Dual Role of PDCD10 in Cancers: A Promising Therapeutic Target
por: Liu, Jingdian, et al.
Publicado: (2022) -
Targeting Aggressive Pituitary Adenomas at the Molecular Level—A Review
por: Voellger, Benjamin, et al.
Publicado: (2021) -
Pituitary Crooke Cell Adenoma: Two Cases of an Aggressive Pituitary Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2023) -
Surgical treatment of aggressive pituitary adenomas and pituitary carcinomas
por: Buchfelder, Michael, et al.
Publicado: (2020) -
Temozolomide in aggressive pituitary adenomas and carcinomas
por: Ortiz, Leon D., et al.
Publicado: (2012)